CX3CR1 Recombinant Rabbit Monoclonal Antibody (1H14L7)
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0464985
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $515.48
About this award
The University of Virginia awarded contract A207_PO-0464985 to Life Technologies Corporation on August 4, 2026, for the procurement of specialized laboratory reagents. The contract encompasses the delivery of CX3CR1 Recombinant Rabbit Monoclonal Antibody (1H14L7), a single unit to be delivered to Mary Young. The contract value totals $515.48, representing a straightforward procurement transaction for research or diagnostic purposes.
Life Technologies Corporation, as the prime contractor, is responsible for fulfilling this purchase order within the Commonwealth of Virginia. The contract documents do not specify an extended performance period or annual value, indicating this is a one-time procurement transaction rather than an ongoing service agreement. The monoclonal antibody product represents a consumable research material commonly utilized in immunological assays and laboratory analysis, typical of academic and research institution purchasing activities.
Line items
| Item | Total |
|---|---|
| CX3CR1 Recombinant Rabbit Monoclonal Antibody (1H14L7) | $515.48 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0464985?
Contract A207_PO-0464985 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on August 4, 2026.
How much is contract A207_PO-0464985 worth?
Its cumulative value is $515.48.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award